• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: MS

Vitamin D and MS: conflicting evidence of clinical benefit

February 27, 2013  

RIS: what are the risk factors for CIS/MS?

February 13, 2013  

The Year in (P)review – MS 2013 – Is the Injectable Era (almost) Over?

January 31, 2013  

RIS: what are the risk factors for CIS/MS?

December 26, 2012  

Neuroprotection: This is your brain on tea

December 5, 2012  

FDA delays review of alemtuzumab

November 7, 2012  

Aubade for Aubagio: FDA approves teriflunomide in RRMS

October 24, 2012  

BG-12: Updated data from phase III studies

August 29, 2012  

What is the optimal dosing of natalizumab?

July 25, 2012  

Breastfeeding not a sustainable therapy

July 11, 2012  
Previous
35
36
37
38
39
Next

Browse by Topic

  • MS (442)
  • EAN 2026 (2)
  • CLINICAL CASES (21)
  • AAN 2026 (3)
  • ACTRIMS Forum 2026 (4)
  • EPILEPSY (38)
  • AES 2025 (1)
  • BIOMARKERS IN MS (61)
  • ECTRIMS 2025 (7)
  • Library (18)
  • EAN 2025 (2)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
  • Anti-CD20 therapy in MS: comparing efficacy and safety posted on July 21, 2026
  • Management of refractory epilepsy: highlights from ILAE 2025 posted on October 29, 2025
Copyright 2026 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions